Why there’s no such thing as an ‘antidepressant’

Antidepressants have been in the news recently. The general feeling seems to be that although they are being overused and may have some unpleasant side effects, they certainly ‘work,’ at least in some people (1).

So what is the evidence that antidepressants ‘work’? If you compare them with a dummy tablet or placebo in a randomised trial, scores on rating scales that are meant to measure depression sometimes go down a few points more in people taking antidepressants compared to people on placebo. But what does this mean? Well, firstly, the differences are small. The commonly used Hamilton Rating Scale for Depression has a maximum score of 54 points and across studies  differences are less than two points (2). A two point difference is unlikely to have any real (clinical) significance. Whether these scales actually measure a complex emotional state like depression is another question.  They consist of lists of symptoms that are sometimes, but not always, associated with depressed mood. A two point change can occur because someone is sleeping better and may have no relation to the individual’s underlying mood.

But the real problem is that placebo controlled trials are not a level playing field. As I have highlighted in my blog on ’models of drug action’ (https://joannamoncrieff.com/2013/11/21/models-of-drug-action/) antidepressants are psychoactive substances. They make people feel different, both physically and mentally. The older ‘tricyclic’ antidepressants, such as amitriptyline, were profoundly sedating. There was no mistaking that you were taking them. The psychoactive effects of the newer antidepressants like fluoxetine (Prozac), paroxetine (Seroxat or Paxil) and venlafaxine (Effexor) are more subtle, but nevertheless present. They seem to make people a little drowsy sometimes, and lethargic. They reduce sexual drive, and in some people they produce a state of emotional detachment or indifference. Some people experience unpleasant feelings of tension or agitation (3).

The psychoactive effects of antidepressant drugs can affect the results of placebo controlled trials in two ways. Firstly, they may directly affect scores on depression rating scales. The emotional detachment produced by selective serotonin reuptake inhibitors (SSRIs) and similar drugs may reduce or blunt negative emotions, so people will rate themselves as less depressed. The sedative effects of the tricyclic antidepressants can improve sleep and reduce anxiety. Since these factors feature prominently in depression-measuring scales, these effects will produce an apparent improvement in depression, despite the fact that there may be no change in the individual’s actual mood (although of course feeling less anxious and sleeping better might improve one’s mood too).

Secondly, the mental alterations produced by psychoactive drugs, alongside their physical effects, may also affect depression ratings in randomised trials by signalling to people that they are taking the active substance rather than the placebo. This is what has been called the ‘amplified placebo effect’ (4).  We use placebos in randomised trials because we know that the expectation that the drug will make you better increases people’s chances of actually getting better. Using a placebo is meant to guard against the role of expectations, but if people can guess whether they have had the active drug or the placebo, then this safeguard no longer operates. We know that people can usually guess better than chance whether they are on the active drug or placebo in randomised controlled trials of antidepressants and other drugs used in psychiatry (5).

If this is the case, people taking the active drug will have greater expectations of success than those on the placebo. So people in the placebo group get the ordinary placebo effect of thinking they are taking a drug, but people in the antidepressant group get an ‘amplified placebo effect’ because they don’t just think they are taking a drug, they have evidence (in the form of subjectively detectable drug-induced alterations) that they really are. An ‘amplified placebo effect’ is especially likely to occur if people enrolled in the study have a bias towards drug treatment in the first place. Since people who don’t want to take antidepressants would usually not take part in a drug trial, this is likely to be the case.  

The direct impact of the psychoactive effects of antidepressants, together with the amplified placebo effect, mean that we cannot interpret the differences between antidepressants and placebo that occur in some randomised controlled trials as evidence that antidepressant drugs have ‘antidepressant’ effects. In other words, these differences do not demonstrate that the drugs reverse part of the underlying mechanism that leads to depressive symptoms. They only show that the experience of taking a drug with psychoactive effects is different from that of taking a sugar pill.

Consistent with this view, almost any type of drug with psychoactive properties has been shown to have ‘antidepressant-like’ effects in one study or another, including stimulants, benzodiazepines and  antipsychotics (6). Substances without noticeable psychoactive or physical effects have not (7).  The fact that antidepressants come from a wide range of chemical classes, and produce an enormous variety of physical and mental alterations, also supports the idea that it is the presence of these alterations and not any specific chemical mechanism that produces the effects seen in placebo- controlled trials.

Drugs might be useful in depression, however, even if they are acting through their psychoactive effects and not reversing an underlying pathology. The sedative effects of the older tricyclic antidepressants and some of the newer ones might be useful in facilitating sleep and reducing agitation. The emotional detachment or indifference produced by the SSRIs may come as a relief to some people who are deeply distressed. The wide-spread promotion of the idea that depression is caused by a chemical imbalance and that antidepressants help put it right means that most people do not expect the drugs to work in this way, however. Indeed, there is so little coverage of the psychoactive effects of antidepressants that it is likely that most doctors are only dimly aware of them.

Moreover, the psychoactive effects of the drugs we call ‘antidepressants’ do not come cost free, of course. SSRIs cause high rates of sexual dysfunction, including reduced libido which is probably an aspect of the emotional indifference they produce (3). Occasionally they seem to precipitate suicidal thoughts and inclinations and there are also withdrawal effects to consider. A minority of people have severe and prolonged withdrawal reactions (8).

Using psychoactive substances to cope with negative emotions is a longstanding human response, but also one that is fraught with difficulty. Although drug-induced effects may bring temporary relief, they may also hamper people from finding more lasting solutions to their problems. If people do want to go down this route, however, there seems no reason to restrict the repertoire to drugs currently called ‘antidepressants’. This raises all sorts of thorny questions, of course, about why some psychoactive drugs are legal and others illegal, about what sort of drug use society approves of and what it doesn’t, and why the legal dispensation of many drugs is restricted to doctors: subjects for many future blogs!


1)      http://www.theguardian.com/society/2013/nov/21/prescribing-culture-blame-rise-antidepressants. 

2)      Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration.. Prevention and Treatment 2002;5.

3)      Goldsmith L, Moncrieff J. The psychoactive effects of antidepressants and their association with suicidality. Curr Drug Saf 2011 Apr;6(2):115-21.

4)      Thomson R. Side effects and placebo amplification. Br J Psychiatry 1982 Jan;140:64-8.

5)      Fisher S, Greenberg RP. How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis 1993 Jun;181(6):345-50.

6)      Moncrieff J. Are antidepressants overrated? A review of methodological problems in antidepressant trials. J Nerv Ment Dis 2001 May;189(5):288-95.

7)      Keller M, Montgomery S, Ball W, Morrison M, Snavely D, Liu G, et al. Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry 2006 Feb 1;59(3):216-23.

8)      Fava M, Mulroy R, Alpert J, Nierenberg AA, Rosenbaum JF. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry 1997 Dec;154(12):1760-2.

27 thoughts on “Why there’s no such thing as an ‘antidepressant’

  1. Pingback: I Am Depressed And I Have Written A Few Things About It | SoshiTech

  2. Pingback: The Disease-Centered Model Vs. The Drug-Centered Model

  3. Pingback: Antidepressants | Hopeworks Community

  4. Pingback: SSRI withdrawal… | Musings of a Dysautonomiac

  5. “A minority of people have severe and prolonged withdrawal reactions (8)”

    I wholeheartedly agree with this statement. Evidence, however, seems to be fundamentally anecdotal. The reference provided, a publication by Fava et al., was a trial on 20 patients for *three days* after discontinuation! “Prolonged” withdrawal effects are to be measured in months or years, not days. The reference clearly does not support Dr Moncrieff’s statement. I don’t know if the reason she does not provide pertinent evidence is because it doesn’t exist, but it probably is. I draw two conclusions from this state of affairs.

    1) There is a deliberate avoidance by the psychiatric research community in recognizing the long term adverse effects of discontinuation. It seems that the avoidance is due to the dishonest posture regarding the benefits/adverse effects of treatment with psycho-active drugs by the psychiatric establishment.

    2) The recognition that, even if psychiatry were interested in elucidating long term adverse reactions to discontinuation, it is practically impossible to demonstrate the causality of the delayed adverse events subsequent to discontinuation. Generating statistical samples showing tenuous correlations is not science. Contradictory “evidence” between studies and conflicting interpretations of results is a hallmark of psychiatric “science”. Given the track record since the 19th century, psychiatry can at best claim the status of pseudo-science, or put more kindly, it’s just an art not a science.

    • I too agree with this blog, as I think there is a biological component to depression as we know certain individuals are more prone to depression than others and that individuals who have had similar experiences to there depressed counterparts, do not develop depression. This suggests that not only is there biological component to depression but a social/environmental one as well. As I believe the way in which we see and ultimately mentally model our environment affects us at a synaptic/genetic level. And sometimes the way in which we react to our environment based upon these models, is dependant on how the individual developed at a neurological level during early childhood and adolescence, which is dependant upon the environment and exposure to environmental factors at that stage of development.
      Thus forming a cyclical model of nature/nurture working together to shape our mental health. Consequently treating depression as purely chemical/neurological issue is only addressing half of the issue. We need to look at the psychosocial factors (stressors) which trigger depression and treat them as well as the underlying neurological factors. For if we identify the triggers and causes for our mental distress and from there develop healthier ways of navigating our way through the world ( developing new mental models) which is why CBT is very effective for depression, the question them becomes do we need antidepressant medication.

  6. Pingback: Do psychiatrists understand psychiatric drugs?

 – Beyond Meds

  7. Pingback: Ocho artículos sobre fármacos antidepresivos y una reflexión sobre el efecto placebo | Gist España

  8. Pingback: Ocho artículos sobre fármacos antidepresivos y una reflexión sobre el efecto placebo | CONTRA CENSURA II

  9. Pingback: ‘Angels and demons’: the politics of psychoactive drugs | Joanna Moncrieff

  10. Pingback: ‘Angels and demons’: the Politics of Psychoactive Drugs | Mad In America

  11. Pingback: ‘Angels and Demons’: the Politics of Psychoactive Drugs | Hypnotherapy

  12. Pingback: Continuing the antidepressant debate: the clinical relevance of drug-placebo differences | Joanna Moncrieff

  13. Pingback: Continuing the Antidepressant Debate: the Clinical Relevance of Drug-Placebo Differences | Mad In America

  14. Useful information. Lucky me I discovered your web site unintentionally, and I am
    shocked why this twist of fate did not came about in advance!

    I bookmarked it.

  15. Pingback: Continuing the Antidepressant Debate: the Clinical Relevance of Drug-Placebo Differences | Neurosciences vs Psychanalyse

    • I agree wholeheartedly, my experience of antidepressants “cured” me of my depression, only because the things that were troubling me at the time disappeared from my mind, along with all thoughts of much else. I was an apathetic zombie for a good portion of my late teens and early twenties. That, coupled with the horrendous side effects of withdrawal, leaves me understanding why some would choose to believe they are better off on antidepressants long term. I also believe that the brain iitself is a much more powerful tool than any chemical. It’s all about intention, in my opinion. The placebo effect has a lot to answer for.

  16. Pingback: Antidepressants, Serotonin and the Pursuit of Happiness | Hearthside Healing

  17. Pingback: Por qué no existen los "Antidepresivos" | DaliaPozo - Psicólogo Valencia

  18. Pingback: Antidepressants – How Do They Work? Types, Choice & List of Antidepressants | UnDepress

  19. How the antidepressant work .either dummy tablet or placebo or antidepressant drugs like tricyclic and ssris.keep the Hamilton rating the maximum 54 and two questionary either depression is clinical and emotional,and randomised trial in a risk group.the result will be at a mean placebo and dummy tablet are helpful in emotional psychosis and depression and drugs like tricyclic and ssris are effective in clinical significant psychosis and depression.

  20. Pingback: Pillshaming is real: here’s a new(ish) way to reduce it, and to reduce antidepressant use | DrNMblog

  21. Pingback: Psychopharmaka | Medizinisches Coaching

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s